MTQUA is an independent organisation set up in 2009 to promote safety and quality in treatment for medical tourists. The organisation assesses participating hospitals across the globe on a variety of parameters ranging from medical quality and outcomes, communication and care, value for service, safety and security, and attention to the special needs of medical travellers.
Complementing the team on receiving the MTQUA award, Aditya Vij, CEO, India, Fortis Healthcare Ltd, said, “Fortis Bannerghatta Road has had a fine tradition of medical excellence. We are proud that we have received the MTQUA award for the fourth year running. The Fortis BG road hospital, along with other Fortis establishments have been instrumental in putting India on the medical tourism map, as a destination for honest, high calibre, complex medical work at a reasonable price point. We are confident that more patients will continue to come to India and to our hospitals for medical treatment and go back satisfied, relieved of their symptoms and pleased with their medical outcomes.”
“This recognition validates our global standing as an institute of clinical excellence and reinforces our commitment to all our patients,” said Mr. P Davison, Zonal Director, Fortis Hospitals Bangalore. “We have also been ranked as the best hospital in Bangalore for cardiac care by the 8th annual Outlook Hospital Survey, 2012,” he added.
People travelling abroad for medical treatment are vulnerable to perils like high risk of infections, over-medication, wrong or poor quality medication, overcharging and deliberately prolonged hospital stays. The award vindicates and allays such fears.
The medical tourism market is currently estimated to be around US$100 billion and is expected to grow to US$ 130 by 2015 at a compound annual growth rate of 15-20%. India is emerging as a major medical tourism destination with more than 1,80,000 visitors travelling to India on a medical visa every year. India’s share of the revenue from medical tourism stands at around US$1.5 billion, and is estimated to grow at a CAGR of 25-30% by 2015. Access to highly specialised doctors and paramedics, sophisticated medical technology and world-class facilities at a much lower cost when compared to developed countries are among the key drivers of medical tourism in India.
Fortis Hospital Bannerghatta had about 650 patients who travelled from various parts of the world like Central, East and West part of Africa, Middle East and some of them also travelled from the United States and Europe. These patients availed tertiary care treatment in specialties like cardiac surgery, knee replacement, complex urological procedures, and brain and spine surgeries.
The hospital is a 400-bed multi-specialty tertiary care hospital has over 150 consultants and 800 paramedical staff. The facility offers services in 40 specialties such as cardiology, cardiac surgery, urology, orthopaedics, neurology, and neurosurgery. The hospital commenced operations in 1999, and is credited with introducing technologies such as custom fit knee and HIFU (High Intensity Focussed Ultrasound) technology for prostate cancer to India.
About Fortis Healthcare Limited
Fortis Healthcare Limited is an integrated healthcare delivery service provider in Asia. The healthcare verticals of the company span primary care, diagnostics, day care speciality and hospitals, with a healthcare network spanning 8 countries. Currently, the company operates its healthcare delivery services in India, Hong Kong, Singapore, Dubai, Mauritius and Sri Lanka with 65 healthcare facilities (including projects under development), over 10,000 potential beds, over 600 primary care centres, 240 diagnostic centres and a team strength of more than 18000 people.
DISCLAIMER
This press release may contain forward-looking statements based on the currently held beliefs and assumptions of the management of the Company, which are expressed in good faith and, in their opinion, reasonable. Forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, financial condition, performance, or achievements of the Company results, to differ materially from the results, financial condition, performance or achievements expressed or implied by such forward-looking statements. Given these risks, uncertainties and other factors, recipients of this press release are cautioned not to place undue reliance on these forward-looking statements. The Company assumes no responsibility to publicly amend, modify or revise any forward looking statements, on the basis of any subsequent development, information or events, or otherwise. The information contained herein is subject to change without notice and past performance is not indicative of future results. The Company may alter, modify or otherwise change in any manner the content of this press release, without obligation to notify any person of such revision or changes.